News

Press Releases

May 24, 2024

Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929 Photoimmunotherapy in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to be Presented at ASCO 2024

May 9, 2024

Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting

April 11, 2024

Rakuten Medical’s Poster Presentation at AACR 2024 Demonstrates Reduction in Photoimmunotherapy-induced Edema in Mice with COX-2 Inhibition

View all

Rakuten Medical Stories

Press Kit

Events & Presentations

About Us

About Us
Letter from Our CEO
Leadership
Location

About

About
Letter from Our CEO
Leadership
Location

Pipeline

Pipeline
Expanded Access Program

Pipeline

Pipeline
Expanded Access Program

News

News
Press Releases
Rakuten Medical Stories
Press Kit

News

News
Press Releases
Rakuten Medical Stories
Press Kit

Contact

Privacy Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We use cookies to enhance user experience and to analyze performance and website traffic. View our Privacy Policy for more details.

Cookie Settings Accept All Cookies

Privacy & Cookies Policy

Privacy Overview

We use cookies to enhance user experience and to analyze performance and website traffic. View our Privacy Policy for more details.
Do not sell my personal information

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.

SAVE & ACCEPT

News

Press Releases

Rakuten Medical Stories

November 11, 2019

November 5, 2019

November 4, 2019

Press Kit

Events & Presentations

About Us

Pipeline

News